Shares of Aveo Pharmaceutical (AVEO -48%) resume trading after being halted earlier in the day...

|About: AVEO Pharmaceuticals, Inc. (AVEO)|By:, SA News Editor

Shares of Aveo Pharmaceutical (AVEO -48%) resume trading after being halted earlier in the day following an FDA panel vote of 13 to 1 that its application for Tivozanib did not demonstrate a favorable benefit-to-risk evaluation for the treatment of advanced renal cell carcinoma.